Lowering Healthcare Costs

Lower the Price of Prescription Drugs

West Health is continuing its efforts by focusing the 2019 Summit on three key areas of interest: lowering drug costs, enacting value-based care over fee-for-service models, and price transparency.

Three National Foundations Commit $30 Million To Civica Rx, A Groundbreaking Effort To Address Shortages And High Prices Of Life-Saving Medications

To address the critical risks posed to patients from chronic shortages and rising prices of life-saving generic medications, three national foundations committed $30 million to help establish Civica Rx, a new not-for-profit generic drug company. The Laura and John Arnold Foundation, the Peterson Center on Healthcare and the Gary and Mary West Foundation each committed $10 million, joining seven large U.S. hospital systems representing approximately 500 U.S. hospitals as governing members of Civica Rx. The formation of Civica Rx was announced earlier today.

Click to Learn More

The Opportunity

Today, the high price of healthcare services — including physicians, hospitals and prescription drugs — are at unprecedented levels, creating barriers to access for individuals who need care. Prescription drug prices continue to increase more rapidly than inflation, resulting in an expected growth in spending of 6.3 percent annually. We believe addressing the excessive prices of prescription drugs provides the most immediate opportunity for relief of exorbitant healthcare prices overall.

Our Goal

No one in America should have to worry about going bankrupt when they get sick or choose between filling their prescription and paying rent. We need to rebalance incentives to increase innovation and price competition and prioritize patient access and affordability. Ultimately, we need to ensure that Americans have the ability to secure the prescription drugs they need at a price they can afford.

Medicare must be allowed to negotiate directly with manufacturers on prescription drug prices to get the best deal for patients and the federal government. As the largest purchaser of prescription drugs in the country – with nearly 42 million seniors and people with disabilities accessing prescription drug coverage through its services – Medicare should be able to leverage its’ purchasing power with pharmaceutical companies to get lower prices. With nine out of 10 Americans in agreement, now is the time for immediate action.

Key steps to lowering drug prices include: •  Increasing competition in the generic and biosimilar industry; •  Eliminating anti-competitive behaviors by some brand-name manufacturers that block or delay competition; •  Testing new reimbursement models that promote value, like outcomes-based purchasing; •  Investing in comparative effectiveness research and its dissemination to understand the value of individual prescription drugs; and •  Allowing states responsible flexibility to test innovative models for purchasing prescription drugs.

With 90 percent of America concerned about the high cost of prescription drugs, we must keep pressure on our elected officials to act in the nation’s interest through sustained and effective engagement.

Join Us at the 2019 Healthcare Costs Innovation Summit

The rising cost of healthcare is a growing and major threat to our economy, our financial security and our individual health. For too long, we’ve been paying too much and not getting enough in return. The U.S. healthcare system is on an unsustainable cost trajectory. We have an urgent need to address this cost crisis so that healthcare can become more accessible and more affordable for all Americans. Now is the time.

Learn More

Lowering Healthcare Costs News

Read our CEO’s opinion on the need to lower prescription drug costs
Healthcare Innovation Day 2019 set for April 2 to advance common-sense reforms to slow trajectory of skyrocketing healthcare costs
View All News & Media